Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation. [electronic resource]
Producer: 20050930Description: 8318-24 p. digitalISSN:- 1078-0432
- Antineoplastic Agents -- adverse effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Fibroblast Growth Factor 10
- Fibroblast Growth Factors -- administration & dosage
- Hematologic Neoplasms -- complications
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Male
- Middle Aged
- Placebos
- Safety
- Stomatitis -- drug therapy
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.